Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.75 (1.66%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £42.17m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Growth Guarantee Scheme Accreditation

27 Aug 2024 07:00

RNS Number : 4720B
Time Finance PLC
27 August 2024
 

Time Finance plc

("Time Finance", the "Group" or the "Company")

 

Government Backed Growth Guarantee Scheme Accreditation

 

Financial Calendar Update

 

Time Finance plc, the AIM listed independent specialist finance provider, is pleased to announce that it has been approved as an accredited lending partner under the UK Government's Growth Guarantee Scheme ("GGS") which is administered by the British Business Bank and was launched on 1 July 2024. GGS is the successor scheme to the Recovery Loan Scheme ("RLS") and Coronavirus Business Interruption Scheme ("CBILS") of which the Group was also an accredited lender.

 

The Company additionally announces some key dates in its 2024 Financial Calendar.

 

Growth Guarantee Scheme Accreditation

The British Business Bank has approved Time Vendor Finance Ltd and Time Hard Asset Finance Limited, wholly-owned subsidiaries of the Company, for accreditation as participating lenders under the scheme.

 

The GGS accreditation provides an additional channel for the Group to deliver support to the UK's smaller businesses, adding to the Group's current lending activities alongside Asset Finance, Loan Finance and Invoice Finance. The scheme accreditation provides the added benefit of a government-backed guarantee to loans provided by the Group, the scheme covers 70% of any outstanding balance, post a recovery process.

 

The Group intends to be an active lender for the duration of the Growth Guarantee Scheme.

 

Financial Calendar Update

The Group plans to announce audited annual results for the year ending 31 May 2024 and, simultaneously, its Q1 FY2425 trading update on Wednesday 25 September 2024. The Company proposes to hold its Annual General Meeting on Tuesday 5 November 2024.

 

Ed Rimmer, Chief Executive Officer, commented:

 

"Time Finance has built a strong relationship with the British Business Bank over a number of years working together and I am very pleased we have been approved as an accredited lender under the GGS. This arrangement allows us to further employ the flexibility, speed of service and personal approach that differentiates our offering. As we continue to work towards becoming the specialist funder of choice for UK SMEs, it is relationships like the one we have with the BBB, that will enable us to achieve this ambition. I look forward to updating everyone on our progress with regards to this new scheme and our other achievements in more detail following our results publication in September."

 

 

For further information, please contact:

 

Time Finance plc 01225 474230

Ed Rimmer, Chief Executive Officer

James Roberts, Chief Financial Officer

 

Cavendish Capital Markets (Nominated Adviser and Broker) 0207 220 0500

Ben Jeynes / Dan Hodkinson (Corporate Finance)

Michael Johnson / George Budd / Charlie Combe (Sales and ECM)

 

Walbrook PR 0207 933 8780

Nick Rome / Joe Walker timefinance@walbrookpr.com

 

About Time Finance:

 

Time Finance's purpose is to help UK businesses thrive and survive through the provision of flexible funding facilities. It offers a multi-product range for SMEs concentrating on Asset, Loan and Invoice Finance. While focussed on being an 'own-book' lender, the Group does retain the ability to broke-on deals where appropriate, enabling it to optimize business levels through market and economic cycles.

 

More information is available on the Company website www.timefinance.com.

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSEUFEEELSEFA
Date   Source Headline
9th Jun 20267:00 amRNSLending Book Milestone & Notice of Q4 Update
24th Mar 20267:00 amRNSQ3 Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
27th Jan 20267:00 amRNSInterim Results
16th Dec 20257:00 amRNSHalf-Year Trading Update & Notice of Results
19th Nov 20257:00 amRNSGrant of 2025 LTIP Awards
14th Nov 20251:57 pmRNSExercise of Options & Director/PDMR Shareholdings
12th Nov 20257:00 amRNSLoan Book Update
6th Nov 202512:07 pmRNSResult of AGM
28th Oct 20257:00 amRNSNotice of Trading Update & Investor Presentations
3rd Oct 20257:00 amRNSVesting of Option Awards
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSNotice of AGM
24th Sep 20257:01 amRNSQ1 Trading Update
24th Sep 20257:00 amRNSFinal Results
18th Sep 20257:00 amRNSNotice of Results, Investor Presentation and AGM
1st Aug 20257:00 amRNSExtended Funding Facilities
26th Jun 20257:00 amRNSTrading Update and Notice of Final Results
4th Jun 20257:00 amRNSLaunch of New Investor Hub
6th May 20257:00 amRNSNotice of Q4 Trading Update and of Final Results
25th Mar 20257:00 amRNSQ3 Trading Update
12th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Feb 20257:00 amRNSDirector/PDMR Shareholding
27th Feb 202512:00 pmRNSNotice of Trading Update
11th Feb 20257:00 amRNSLending Portfolio Update
28th Jan 20257:00 amRNSInterim Results
19th Dec 20247:00 amRNSHalf-Year Trading Update & Notice of Results
22nd Nov 20249:03 amRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Update
5th Nov 202412:30 pmRNSResult of AGM
24th Oct 20247:00 amRNSExercise of Options & Director/PDMR Shareholdings
4th Oct 20247:00 amRNSVesting of Option Awards
3rd Oct 20247:00 amRNSDirector share purchases
2nd Oct 20247:00 amRNSExtended & Improved £65m NatWest Funding Facility
26th Sep 20247:00 amRNSNotice of AGM
25th Sep 20247:01 amRNSQ1 Trading Update
25th Sep 20247:00 amRNSFinal Results
10th Sep 20247:00 amRNSNotice of Results, Investor Pres & Trading Update
27th Aug 20247:00 amRNSGrowth Guarantee Scheme Accreditation
3rd Jul 20247:00 amRNSDirector Share Purchase
27th Jun 20247:00 amRNSTrading Update and Notice of Final Results
3rd Apr 20247:00 amRNSExtended & Improved £64m Funding Facility
26th Mar 20247:00 amRNSQ3 Trading Update
5th Mar 20247:00 amRNSNotice of Trading Update
25th Jan 20247:00 amRNSInterim Results
18th Jan 20244:30 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNSHalf-Year Trading Update & Notice of Results
21st Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.